MAIA Biotechnology (MAIA) News Today $1.72 -0.03 (-1.71%) Closing price 06/13/2025 04:10 PM EasternExtended Trading$1.72 0.00 (-0.29%) As of 06/13/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock MAIA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period MAIA Biotechnology to Present at BIO International Convention 2025June 10, 2025 | businesswire.comStan Smith Acquires 33,333 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) StockJune 6, 2025 | insidertrades.comMaia Biotechnology stock rises following positive trial resultsJune 5, 2025 | in.investing.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Stan Smith Purchases 33,333 SharesMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) Director Stan Smith acquired 33,333 shares of MAIA Biotechnology stock in a transaction on Tuesday, June 3rd. The shares were purchased at an average price of $1.50 per share, for a total transaction of $49,999.50. Following the completion of the purchase, the director now directly owns 1,305,059 shares of the company's stock, valued at approximately $1,957,588.50. This represents a 2.62% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link.June 5, 2025 | marketbeat.comMAIA Biotechnology Announces New Responder in Non-Small Cell Lung Cancer Phase 2 Clinical TrialJune 5, 2025 | businesswire.comMAIA Biotechnology Announces Positive Efficacy Update for Phase 2 THIO-101 Clinical Trial in Non-Small Cell Lung CancerJune 5, 2025 | businesswire.comMAIA Biotechnology Showcases Promising THIO-101 Trial DataJune 2, 2025 | tipranks.comMAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer TrialMay 29, 2025 | finance.yahoo.comMAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer TrialMay 27, 2025 | insidermonkey.comCORRECTING and REPLACING MAIA Biotechnology Announces Private Placement of Approximately $695,000May 27, 2025 | businesswire.comMAIA Biotechnology Increases Authorized Common Stock SharesMay 23, 2025 | tipranks.comMAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual MeetingMay 15, 2025 | businesswire.comMAIA Biotechnology Announces Director Participation in Recent Private PlacementMay 14, 2025 | businesswire.comMAIA Biotechnology (MAIA) Projected to Post Quarterly Earnings on TuesdayMAIA Biotechnology (NYSEAMERICAN:MAIA) will be releasing its Q1 2025 earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-maia-biotechnology-inc-stock/)May 8, 2025 | marketbeat.comCORRECTION: MAIA Biotechnology Announces $1.08 Million Private PlacementMay 5, 2025 | businesswire.comMAIA Biotechnology Announces $1.08 Million Private PlacementMay 5, 2025 | businesswire.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest UpdateMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) was the target of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 622,500 shares, a decrease of 15.6% from the March 31st total of 737,400 shares. Currently, 2.9% of the shares of the stock are short sold. Based on an average trading volume of 219,600 shares, the days-to-cover ratio is currently 2.8 days.May 5, 2025 | marketbeat.comMAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to ShareholdersApril 1, 2025 | businesswire.comIs MAIA Biotechnology, Inc. (MAIA)he Cheapest Stock Insiders Are Buying In March?March 28, 2025 | insidermonkey.comMAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025March 25, 2025 | businesswire.comMAIA Biotechnology Gets USAN Approval For "Ateganosine" As Name For Telomere-Targeting DrugMarch 21, 2025 | nasdaq.comMAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimerMarch 21, 2025 | msn.comMAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO ProdrugMarch 20, 2025 | businesswire.comMAIA Biotechnology Receives USAN Council Approval for "Ateganosine" as Nonproprietary Name for Anticancer Agent THIOMarch 19, 2025 | uk.finance.yahoo.comMAIA Biotechnology, Inc. (MAIA) Receives a Buy from Noble FinancialFebruary 28, 2025 | markets.businessinsider.comMAIA Biotechnology to initiate THIO-104 trialFebruary 28, 2025 | markets.businessinsider.comMAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer PatientsFebruary 27, 2025 | businesswire.comMAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung CancerFebruary 26, 2025 | uk.finance.yahoo.comMAIA Biotech announces trial design to expand THIO-101 Phase 2 NSCLC studyFebruary 26, 2025 | markets.businessinsider.comMAIA Biotechnology Announces Design for Expansion of THIO-101 Phase 2 Trial in Advanced Non-Small Cell Lung CancerFebruary 26, 2025 | businesswire.comMAIA Biotechnology Announces Non-Brokered Private Placement of Approximately $1.43 MillionFebruary 24, 2025 | finance.yahoo.comMaia Biotechnology Inc trading resumesFebruary 19, 2025 | markets.businessinsider.comMAIA Biotechnology to sell 1.81M shares at $1.50 in private placementFebruary 19, 2025 | markets.businessinsider.comMaia Biotechnology Inc trading halted, news pendingFebruary 18, 2025 | markets.businessinsider.comMAIA Biotechnology Announces Private Placement of $2,715,000February 18, 2025 | businesswire.comAnalysts Offer Insights on Healthcare Companies: Ocugen (OCGN) and Xilio Therapeutics (XLO)February 13, 2025 | markets.businessinsider.comMAIA Biotech executives receive salary hikes and new termsFebruary 7, 2025 | msn.comMAIA Biotechnology Updates Executive Compensation PackagesFebruary 6, 2025 | tipranks.comMAIA Biotechnology reports promising THIO trial results for NSCLCFebruary 5, 2025 | msn.comMAIA Biotechnology Reports Promising Phase 2 Trial ResultsFebruary 5, 2025 | tipranks.comMAIA Biotechnology announces updated data from THIO-101 trialFebruary 5, 2025 | msn.comMAIA’s lung cancer therapy 99% more likely to improve OS over chemo aloneFebruary 5, 2025 | msn.comMAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung CancerFebruary 4, 2025 | businesswire.comMAIA Biotechnology to Present at Biotech Showcase 2025January 10, 2025 | businesswire.comMAIA Biotechnology enters clinical supply agreement with BeiGene for THIOJanuary 8, 2025 | markets.businessinsider.comHealth Care Up as Vaccine Makers Surge -- Health Care RoundupJanuary 7, 2025 | marketwatch.comMAIA Biotechnology Shares Rise After Supply Agreement With BeiGeneJanuary 7, 2025 | marketwatch.comMAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer IndicationsJanuary 7, 2025 | finance.yahoo.comMAIA Biotechnology Announces Director Participation in Recent Private Placement ClosingsDecember 19, 2024 | finance.yahoo.comNoble Financial Remains a Buy on MAIA Biotechnology, Inc. (MAIA)December 18, 2024 | markets.businessinsider.com Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address MAIA Media Mentions By Week MAIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼0.970.88▲Average Medical News Sentiment MAIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼21▲MAIA Articles Average Week Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LYEL News VTYX News LRMR News NVCT News NMRA News ELDN News DMAC News PBYI News ALTS News ACTU News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 6/14/2025 by MarketBeat.com Staff From Our PartnersThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s worst nightmareThe President’s tour of the Middle East… the deal for Ukraine’s mineral rights… Elon’s strange time in Washing...Porter & Company | SponsoredGet in stocks now - and get out on this dateGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MAIA Stock Free MAIA Stock Alerts